Dow Rises Ahead of Fed Minutes; Moderna Surges on Cancer Drug News
📊 MRNA — Piyasa Yorumu
▲ up · 60%Moderna's cancer drug news creates a positive catalyst for the stock and could generate buying pressure in the short term. Although technical indicators give mixed signals, the RSI being in neutral territory and the price above the 50-day moving average are supportive. The MACD being below the signal line indicates that momentum has not yet fully strengthened, but the news flow could offset this weakness. Overall market sentiment and the rise in the Dow could also increase risk appetite. Therefore, an upward move can be expected in the short term, but a moderate rise is more likely than an extreme jump.
📊 DJI — Piyasa Yorumu
■ neutral · 55%The headline notes that the Dow is rising ahead of the Fed minutes, but this may be short-term optimism. Technical indicators, however, point to weakness: the RSI at 31.8 is near oversold territory, the MACD is negative and below the signal line. The price is below the 20- and 50-day moving averages, confirming a short-term downtrend. The 0.77% decline over the last 24 hours indicates continued selling pressure. Therefore, despite the positive news, the technical outlook remains uncertain, and the Fed minutes should be awaited for direction.